SEER Insider Trading

Insider Ownership Percentage: 15.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $47,578.34

Seer Insider Trading History Chart

This chart shows the insider buying and selling history at Seer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$500k$0$500kTotal Insider BuyingTotal Insider Selling

Seer Share Price & Price History

Current Price: $2.00
Price Change: Price Increase of +0.035 (1.79%)
As of 05/28/2025 12:14 PM ET

This chart shows the closing price history over time for SEER up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JulAugSepOctNovDecJanFebMarAprMay$1.96Closing price on 05/27/25:

SEC Filings (Institutional Ownership Changes) for Seer (NASDAQ:SEER)

75.20% of Seer stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SEER by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$698kbought$82ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$4M-$2M$0$2M$4MTotal InflowsTotal Outflows
Seer logo
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Read More on Seer

Today's Range

Now: $2.00
Low: $1.96
High: $2.01

50 Day Range

MA: $1.94
Low: $1.66
High: $2.11

52 Week Range

Now: $2.00
Low: $1.56
High: $2.63

Volume

74,684 shs

Average Volume

330,132 shs

Market Capitalization

$119.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

Who are the company insiders with the largest holdings of Seer?

Seer's top insider investors include:
  1. Omid Farokhzad (CEO)
  2. David R Horn (CFO)
  3. Elona Kogan (Insider)
  4. Elona Esq Kogan (Insider)
  5. Dipchand Nishar (Director)
Learn More about top insider investors at Seer.

Who are the major institutional investors of Seer?

Seer's top institutional investors include:
  1. Jacobs Levy Equity Management Inc. — 0.61%
  2. Jane Street Group LLC — 0.43%
  3. Invesco Ltd. — 0.32%
  4. Goldman Sachs Group Inc. — 0.29%
  5. OMERS ADMINISTRATION Corp — 0.13%
  6. Simplex Trading LLC — 0.00%
Learn More about top institutional investors of Seer stock.

Which major investors are selling Seer stock?

During the last quarter, SEER stock was sold by these institutional investors:
  1. Invesco Ltd.
During the last year, company insiders that have sold Seer company stock include:
  1. Omid Farokhzad (CEO)
  2. David R Horn (CFO)
  3. Elona Kogan (Insider)
Learn More investors selling Seer stock.

Which major investors are buying Seer stock?

In the previous quarter, SEER stock was acquired by institutional investors including:
  1. Jacobs Levy Equity Management Inc.
  2. Jane Street Group LLC
  3. Goldman Sachs Group Inc.
  4. OMERS ADMINISTRATION Corp